DoD Duchenne Muscular Dystrophy Therapeutic Idea Award

Archived

Defense Health Agency Contracting Activity - DHACA

Description

The DMDRP Therapeutic Idea Award mechanism was first offered in FY12 and is being offered again in FY14. It is designed to promote new ideas that are still in the early stages of development with the potential to yield high-impact data and new avenues of investigation for novel therapeutics for DMD treatment. This award mechanism supports conceptually innovative, high-risk/high-reward research that could ultimately lead to critical discoveries or major advancement in DMD therapeutics. Research projects should include a well-formulated, testable hypothesis based on strong scientific rationale.Presentation of preliminary data is not consistent with the intent of the Therapeutic Idea Award mechanism. While the inclusion of preliminary data is not prohibited, the strength of the application should not rely on preliminary data.

Who can apply

  • Unrestricted

Contact

Phone: (301) 682-5507 <br/>Email: help@eBRAP.org
help@eBRAP.org

Key dates & funding
  • PostedMay 27, 2014
  • ClosesOct 22, 2014
  • Program funding$480,000
  • Expected awards1
  • CFDA12.420

Pro insight

Edit and export this grant’s proposal template, plus deadline reminders, similar-grant suggestions, and funder history — all available with Pro.

Unlock with Pro